Applications of 3-(2-Chloroethyl)-2-Methylpyrido[1,2-A]Pyrimidin-4-One in Industrial Manufacturing

As the original manufacturer of 3-(2-Chloroethyl)-2-Methylpyrido[1,2-A]Pyrimidin-4-One, we supply this active intermediate to clients across highly specialized industries. The material's reactivity profile and substitution pattern enable demanding, controlled-use applications across regulated pharmaceutical synthesis and fine chemical manufacturing environments. Each application scenario below reflects actual, validated downstream industrial uses based on current market practice; content is informed by typical industry frameworks, production steps, and the specific requirements of technical customers.

1. Synthesis of Targeted Kinase Inhibitor Pharmaceuticals

Pharmaceutical manufacturers incorporate this pyridopyrimidinone core structure as a key building block in synthesizing kinase inhibitor drug substances for oncology research and advanced-stage medications. Its chloroethyl functionality participates in late-stage alkylation steps, forming covalent bonds that define drug selectivity and potency. Each QC protocol emphasizes impurity control to meet stringent health authority expectations for small-molecule APIs produced via multi-step route with in situ intermediate purification.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• EU GMP Part II; US FDA 21 CFR Part 210/211
• Relevant monographs in USP, Ph. Eur. (where structure is referenced)
• REACH registration for starting material traceability

Typical usage ratio

• 5–15% molar equivalent in related alkylation or condensation steps, adjusted based on targeted specificity and downstream protecting group strategies

Downstream process integration

• Introduced after core pyridopyrimidinone scaffold formation, reacts at controlled temperature with protected amines or aryl substrates under inert conditions. Post-reaction, intermediates advance to purification by preparative HPLC or crystallization before final deprotection steps.

Final product types

• Small-molecule kinase inhibitors, cytostatic bulk APIs, research-stage oncology candidates, custom pharmaceutical intermediates

2. Manufacture of Agrochemical Active Ingredients (Pyridopyrimidine Herbicides)

Producers of selective herbicidal compounds employ this intermediate as a heterocycle source in the multi-step synthesis of pre-emergent and post-emergent crop protection agents. The chloroethyl moiety supports side-chain customization to improve target weed specificity and metabolic stability, especially in field-ready preformulations meeting stringent residue and safety requirements.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for agrochemical APIs
• OECD/FAO Registration Guidelines for Active Substances
• EU Regulation (EC) No 1107/2009 (Plant Protection Products)
• Local environmental health and safety directives on trace contaminants

Typical usage ratio

• 2–8% w/w relative to main formulation batch, modulated by the mode-of-action group and final product loading

Downstream process integration

• Fed into catalytic alkylation or condensation reactors following initial pyridopyrimidine backbone formation; subsequent stages often feature selective chlorination, isomer separation, and in-line filtration before blending into preconcentrates for standard field formulations.

Final product types

• Selective herbicide active ingredients, granular field formulations, water-dispersible granules, concentrated suspension concentrates (SCs)

3. Fine Chemical Intermediate for Specialty Dye & Pigment Synthesis

Specialty colorant makers utilize this compound as a precursor in synthesizing high-performance dyes and pigments, particularly those requiring extended conjugation and durable aromatic frameworks. The controlled reactivity of its chloroethyl group supports attachment of alkyl or aryl side chains, stabilizing the resulting chromophore against photolytic and chemical degradation in demanding application settings.

Industry compliance standards

• ISO 9001:2015 Certification for specialty colorant manufacture
• EN 71-3:2019 (Safety of Toys – Migration of Certain Elements) for pigment safety in relevant markets
• Compliance with REACH SVHC and specific customer restricted substance lists (RSL)
• ASTM D4236 (Labeling of Art Materials for Chronic Health Hazards)

Typical usage ratio

• 3–12% w/w in stepwise pigment or dye condensation, dependent on desired color depth, substituent effect, and application environment

Downstream process integration

• Incorporated as a late-stage condensation or coupling partner, often under high-temperature, solvent-assisted protocols; intermediate pigments undergo purification, filtration, and sometimes salt formation before final dispersion or milling into use-ready product forms.

Final product types

• High-performance dyes for polyester fibers, automotive and industrial grade pigments, imaging inks, color masterbatch concentrates

4. Research-Scale Tool Compound Synthesis for Medicinal Chemistry Laboratories

Contract R&D organizations and in-house pharmaceutical innovation labs source this intermediate to create compound libraries for structure-activity relationship (SAR) studies aimed at novel bioactive scaffolds. The chloroethyl handle permits rapid diversification through nucleophilic substitution, enabling parallel library synthesis under automated workflows constrained by GLP and research-grade purity norms.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• Internal corporate screening library acquisition guidelines
• Material Safety Data Sheet (MSDS)/GHS chemical safety documentation
• Waste handling per regional environmental regulations (e.g., EU RoHS/REACH compliance)

Typical usage ratio

• 5–25 mg per well or synthesis batch, with scalability based on fragment optimization needs and parallel synthesis throughput

Downstream process integration

• Charged into batchwise microwave-assisted or microfluidic reactors as the alkylation partner, enabling rapid hit-to-lead conversion followed by preparative LC/MS purification ahead of target validation workflows.

Final product types

• Fragment-based screening compounds, bioactive tool molecules, SAR-point variants, focused compound library mixtures

5. Custom Synthesis Feedstock for High-Purity Heterocyclic Compounds

Advanced material suppliers and specialty fine chemical producers use this building block to access unique heterocyclic chemotypes with application in chemical sensor devices, electronic materials research, and advanced material science investigations. Its substitution triggers specific electronic effects, crucial in the stepwise assembly of large, π-extended heterocyclic frameworks evaluated for niche device and analytical markets.

Industry compliance standards

• ISO 9001:2015 for fine chemical design and production
• Customer specification-driven QC based on NMR, HPLC, and elemental analysis
• REACH and TSCA notification as required for specialty chemicals
• MSDS/GHS chemical safety disclosure

Typical usage ratio

• Varies from 1–10% molar basis, dictated by the polymerization/cyclization protocol and desired electronic properties of the end product

Downstream process integration

• Employed as the primary or coupling heterocycle in stepwise assembly, introduced at specific points under controlled temperature and atmosphere; intermediates purified by column chromatography or crystallization before QC release and transfer to device manufacturers or research labs.

Final product types

• Heterocyclic sensor mediators, specialty organic semiconductors, molecular scaffolds for electronics, advanced analytical reference materials